US Stock MarketDetailed Quotes

BCDA BioCardia

Watchlist
  • 3.050
  • +0.630+26.03%
Close Apr 29 16:00 ET
  • 3.060
  • +0.010+0.33%
Pre 09:00 ET
14.27MMarket Cap-1.05P/E (TTM)

BioCardia Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-87.84%58K
0
0
-93.02%3K
-14.06%55K
-64.72%477K
-87.74%13K
68.40%357K
-95.59%43K
6.67%64K
Operating revenue
-87.84%58K
--0
--0
-93.02%3K
-14.06%55K
-64.72%477K
-87.74%13K
68.40%357K
-95.59%43K
6.67%64K
Cost of revenue
Gross profit
Operating expense
-33.51%8.06M
10.68%2.32M
-40.58%1.76M
-52.73%1.65M
-34.81%2.33M
-8.54%12.12M
-32.87%2.1M
-9.69%2.96M
0.72%3.5M
5.52%3.57M
Selling and administrative expenses
-16.45%3.67M
-3.72%906K
-23.82%825K
-27.86%852K
-8.49%1.09M
-0.54%4.4M
1.84%941K
-3.99%1.08M
1.29%1.18M
-0.92%1.19M
Research and development costs
-43.22%4.39M
22.40%1.42M
-50.27%931K
-65.43%800K
-47.94%1.24M
-12.54%7.73M
-47.45%1.16M
-12.69%1.87M
0.43%2.31M
9.06%2.38M
Operating profit
31.29%-8M
-11.37%-2.32M
32.41%-1.76M
52.23%-1.65M
35.19%-2.28M
2.16%-11.64M
30.95%-2.08M
15.10%-2.6M
-38.30%-3.45M
-5.50%-3.51M
Net non-operating interest income expense
Other net income (expense)
-24.66%55K
108.33%25K
-20.83%19K
-89.29%3K
-11.11%8K
1,316.67%73K
220.00%12K
700.00%24K
2,900.00%28K
350.00%9K
Other non- operating income (expenses)
-24.66%55K
108.33%25K
-20.83%19K
-89.29%3K
-11.11%8K
1,316.67%73K
220.00%12K
700.00%24K
2,900.00%28K
350.00%9K
Income before tax
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
15.80%-2.57M
-37.12%-3.42M
-5.29%-3.5M
Income tax
Net income
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
15.80%-2.57M
-37.12%-3.42M
-5.29%-3.5M
Net income continuous Operations
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
15.80%-2.57M
-37.12%-3.42M
-5.29%-3.5M
Minority interest income
Net income attributable to the parent company
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
15.80%-2.57M
-37.12%-3.42M
-5.29%-3.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
15.80%-2.57M
-37.12%-3.42M
-5.29%-3.5M
Basic earnings per share
64.59%-2.9
62.19%-0.499
65.92%-0.61
65.08%-0.88
47.06%-1.35
18.51%-8.19
45.00%-1.32
29.80%-1.79
-20.00%-2.52
10.53%-2.55
Diluted earnings per share
64.59%-2.9
62.19%-0.499
65.92%-0.61
65.08%-0.88
47.06%-1.35
18.51%-8.19
45.00%-1.32
29.80%-1.79
-20.00%-2.52
10.53%-2.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -87.84%58K00-93.02%3K-14.06%55K-64.72%477K-87.74%13K68.40%357K-95.59%43K6.67%64K
Operating revenue -87.84%58K--0--0-93.02%3K-14.06%55K-64.72%477K-87.74%13K68.40%357K-95.59%43K6.67%64K
Cost of revenue
Gross profit
Operating expense -33.51%8.06M10.68%2.32M-40.58%1.76M-52.73%1.65M-34.81%2.33M-8.54%12.12M-32.87%2.1M-9.69%2.96M0.72%3.5M5.52%3.57M
Selling and administrative expenses -16.45%3.67M-3.72%906K-23.82%825K-27.86%852K-8.49%1.09M-0.54%4.4M1.84%941K-3.99%1.08M1.29%1.18M-0.92%1.19M
Research and development costs -43.22%4.39M22.40%1.42M-50.27%931K-65.43%800K-47.94%1.24M-12.54%7.73M-47.45%1.16M-12.69%1.87M0.43%2.31M9.06%2.38M
Operating profit 31.29%-8M-11.37%-2.32M32.41%-1.76M52.23%-1.65M35.19%-2.28M2.16%-11.64M30.95%-2.08M15.10%-2.6M-38.30%-3.45M-5.50%-3.51M
Net non-operating interest income expense
Other net income (expense) -24.66%55K108.33%25K-20.83%19K-89.29%3K-11.11%8K1,316.67%73K220.00%12K700.00%24K2,900.00%28K350.00%9K
Other non- operating income (expenses) -24.66%55K108.33%25K-20.83%19K-89.29%3K-11.11%8K1,316.67%73K220.00%12K700.00%24K2,900.00%28K350.00%9K
Income before tax 31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M15.80%-2.57M-37.12%-3.42M-5.29%-3.5M
Income tax
Net income 31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M15.80%-2.57M-37.12%-3.42M-5.29%-3.5M
Net income continuous Operations 31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M15.80%-2.57M-37.12%-3.42M-5.29%-3.5M
Minority interest income
Net income attributable to the parent company 31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M15.80%-2.57M-37.12%-3.42M-5.29%-3.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M15.80%-2.57M-37.12%-3.42M-5.29%-3.5M
Basic earnings per share 64.59%-2.962.19%-0.49965.92%-0.6165.08%-0.8847.06%-1.3518.51%-8.1945.00%-1.3229.80%-1.79-20.00%-2.5210.53%-2.55
Diluted earnings per share 64.59%-2.962.19%-0.49965.92%-0.6165.08%-0.8847.06%-1.3518.51%-8.1945.00%-1.3229.80%-1.79-20.00%-2.5210.53%-2.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
381.450
Tesla
TSLA
292.030
MARA Holdings
MARA
14.220
4
Meta Platforms
META
554.440
5
Salesforce
CRM
267.760
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀